Journal of Clinical Medicine Research, ISSN 1918-3003 print, 1918-3011 online, Open Access |
Article copyright, the authors; Journal compilation copyright, J Clin Med Res and Elmer Press Inc |
Journal website http://www.jocmr.org |
Original Article
Volume 8, Number 5, May 2016, pages 373-378
Factors Influencing Changes in Hemoglobin A1c and Body Weight During Treatment of Type 2 Diabetes With Ipragliflozin: Interim Analysis of the ASSIGN-K Study
Figure
Tables
Characteristics | |
---|---|
SD: standard deviation; BMI: body mass index; HbA1c: hemoglobin A1c; NGSP: National Glycohemoglobin Standardization Program; eGFR: estimated glomerular filtration rate. | |
Number | 257 |
Age, mean ± SD | 53.9 ± 10.4 |
< 65 years, n (%) | 215 (83.7) |
≥ 65 years, n (%) | 42 (16.3) |
Sex | |
Male, n (%) | 123 (47.9) |
Female, n (%) | 134 (52.1) |
Weight, kg, mean ± SD | 80.3 ± 17.4 |
BMI, kg/m2, mean ± SD | 30.0 ± 5.4 |
HbA1c, % (NGSP), mean ± SD (n) | 8.2 ± 1.5 (254) |
Fasting glucose, mg/dL, mean ± SD (n) | 158.5 ± 43.6 (110) |
Postprandial glucose, mg/dL, mean ± SD (n) | 199.1 ± 85.2 (93) |
Duration of diabetes, years, mean ± SD (n) | 9.6 ± 6.9 (248) |
Systolic blood pressure, mm Hg, mean ± SD (n) | 131.3 ± 15.9 (254) |
Diastolic blood pressure, mm Hg, mean ± SD (n) | 78.3 ± 10.6 (254) |
eGFR, mL/min/1.73 m2, mean ± SD | 83.89 ± 21.67 |
< 60 mL/min/1.73 m2, n (%) | 31 (12.3) |
≥ 60 mL/min/1.73 m2, n (%) | 222 (87.7) |
Drinking alcohol | |
Yes, number (%) | 87 (33.9) |
No, number (%) | 169 (65.8) |
Smoking tobacco | |
Yes, number (%) | 78 (30.4) |
No, number (%) | 178 (69.3) |
n | Baseline | Week 4 | Week 12 | |
---|---|---|---|---|
Analysis of variance: vs. baseline *P < 0.01, week 4 vs. week 12 †P < 0.01. HbA1c: hemoglobin A1c; BMI: body mass index. | ||||
HbA1c, % | 257 | 8.23 | 7.81* | 7.55*† |
Fasting glucose, mg/dL | 110 | 158.5 | 139.2* | 134.6* |
Postprandial glucose, mg/dL | 93 | 199.1 | 161.0* | 154.9* |
Body weight, kg | 240 | 79.9 | 78.8* | 78.1*† |
BMI, kg/m2 | 241 | 29.9 | 29.5* | 29.2*† |
Waist circumference, cm | 250 | 101.2 | 99.9* | 99.0*† |
Independent variable | Standardized coefficient β | Partial regression coefficient | P value |
---|---|---|---|
n = 243. Stepwise analysis with the following independent variables: age, sex, duration of diabetes, baseline HbA1c, baseline BMI, and treatment category (new monotherapy, concurrent administration, or switching treatment). Dependent variable: decrease in HbA1c. BMI: body mass index; HbA1c: hemoglobin A1c. | |||
Constant | 0 | 2.050 | 0.0034 |
Age | 0.020 | 0.002 | 0.7324 |
Sex | 0.081 | 0.203 | 0.1196 |
Duration of diabetes | 0.205 | 0.037 | 0.0003 |
BMI (baseline) | 0.080 | 0.019 | 0.1213 |
HbA1c (baseline) | -0.585 | -0.485 | < 0.0001 |
Switching treatment | 0.206 | 0.806 | < 0.0001 |
Independent variable | Standardized coefficient β | Partial regression coefficient | P value |
---|---|---|---|
n = 238. Stepwise analysis with the following independent variables: age, sex, duration of diabetes, baseline HbA1c, and baseline BMI. Dependent variable: decrease in body weight. BMI: body mass index; HbA1c: hemoglobin A1c. | |||
Constant | 0 | -0.117 | 0.9422 |
Age | -0.065 | -0.015 | 0.3714 |
Sex | -0.092 | -0.436 | 0.1447 |
Duration of diabetes | 0.051 | 0.018 | 0.4502 |
BMI (baseline) | -0.237 | -0.111 | 0.0002 |
HbA1c (baseline) | 0.215 | 0.334 | 0.0005 |